GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Hamlet BioPharma AB publ (XSAT:HAMLET B) » Definitions » Liabilities-to-Assets

Hamlet BioPharma AB publ (XSAT:HAMLET B) Liabilities-to-Assets : 0.08 (As of Mar. 2025)


View and export this data going back to 2015. Start your Free Trial

What is Hamlet BioPharma AB publ Liabilities-to-Assets?

Liabilities-to-Assets is a solvency ratio indicating how much of the company’s assets are made of liabilities, calculated as total liabilities divided by total asset. Hamlet BioPharma AB publ's Total Liabilities for the quarter that ended in Mar. 2025 was kr4.76 Mil. Hamlet BioPharma AB publ's Total Assets for the quarter that ended in Mar. 2025 was kr58.58 Mil. Therefore, Hamlet BioPharma AB publ's Liabilities-to-Assets Ratio for the quarter that ended in Mar. 2025 was 0.08.


Hamlet BioPharma AB publ Liabilities-to-Assets Historical Data

The historical data trend for Hamlet BioPharma AB publ's Liabilities-to-Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hamlet BioPharma AB publ Liabilities-to-Assets Chart

Hamlet BioPharma AB publ Annual Data
Trend Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
Liabilities-to-Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.28 0.78 0.09 0.27 0.06

Hamlet BioPharma AB publ Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Liabilities-to-Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.06 0.06 0.08 0.07 0.08

Competitive Comparison of Hamlet BioPharma AB publ's Liabilities-to-Assets

For the Biotechnology subindustry, Hamlet BioPharma AB publ's Liabilities-to-Assets, along with its competitors' market caps and Liabilities-to-Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hamlet BioPharma AB publ's Liabilities-to-Assets Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Hamlet BioPharma AB publ's Liabilities-to-Assets distribution charts can be found below:

* The bar in red indicates where Hamlet BioPharma AB publ's Liabilities-to-Assets falls into.


;
;

Hamlet BioPharma AB publ Liabilities-to-Assets Calculation

Liabilities-to-Assets ratio measures the portion of the total liabilities to the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Liabilities-to-Assets ratio is calculated by dividing total liabilities by total asset.

Hamlet BioPharma AB publ's Liabilities-to-Assets Ratio for the fiscal year that ended in Jun. 2024 is calculated as:

Liabilities-to-Assets (A: Jun. 2024 )=Total Liabilities/Total Assets
=4.108/68.566
=0.06

Hamlet BioPharma AB publ's Liabilities-to-Assets Ratio for the quarter that ended in Mar. 2025 is calculated as

Liabilities-to-Assets (Q: Mar. 2025 )=Total Liabilities/Total Assets
=4.762/58.577
=0.08

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Hamlet BioPharma AB publ  (XSAT:HAMLET B) Liabilities-to-Assets Explanation

Liabilities-to-Assets is a solvency ratio indicating how much of the company’s assets are made of liabilities. It can vary greatly across different industries, as they have different capital structure. A high Liabilities-to-Assets ratio (more leveraged) suggests that the company might have potential solvency problems, or even a signal of financial distress. Conversely, a low Liabilities-to-Assets ratio usually indicates a healthy financial situation. However, it may also suggest that the company is not expanding or not making good use of debt.


Hamlet BioPharma AB publ Liabilities-to-Assets Related Terms

Thank you for viewing the detailed overview of Hamlet BioPharma AB publ's Liabilities-to-Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


Hamlet BioPharma AB publ Business Description

Traded in Other Exchanges
Address
Klinikgatan 32, BMC D10, Lund, SWE, SE-222 42
Hamlet BioPharma AB publ is a pharmaceutical company engaged in the research and development of drugs used for curing cancer.

Hamlet BioPharma AB publ Headlines

No Headlines